glp 1 nutritional deficiency GLP-1 therapy is becoming a widespread pharmaceutical treatment for obesity and type 2 diabetes, but there are side effects. Many users develop deficiencies in critical nutrients like vitamin D, iron, and B Nutritional deficiencies and muscle loss

Monitoring is important, especially for people with metabolic concerns, cancer history, or endocrine disorders

Common GLP-1 drugs include: Semaglutide (sold as Ozempic, Wegovy, or Rybelsus) Tirzepatide (sold as Mounjaro or Zepbound) Liraglutide (sold as Victoza or Saxenda) Dulaglutide (sold as Trulicity) Exenatide (sold as Byetta) These medications work by slowing down your digestion

Our clinical decisions are guided by: The strength and quality of available evidence Individual medical and psychiatric history Safety, side-effect profiles, and long-term risk How any new approach integrates with comprehensive, whole-person care If GLP-1 medications eventually prove safe and effective for certain patients with substance use disorders, they would be considered as part of a broader, medically directed treatment plannever as a standalone quick fix. In the meantime, my advice to patients is straightforward: have this conversation with your treatment team

Pharmacological therapies targeting GPX4 are a promising strategy for inducing ferroptosis in cancer cells, including clear-cell carcinomas that resistant to conventional treatments [49]